TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Certified by Founder
Lodge
LFX Venture Partners
investor
United States
- Los Angeles, California
- 14/11/2022
- Series A
- $23,000,000
LFX Venture Partners is a venture capital firm focused on the upstream supply chain that is largely manual, which makes it prime for disruption. Upstream supply chain must be modernized to create a supply chain that is far more responsive to consumers' needs.
We are located in Silicon Valley and Los Angeles, and run by 2 fund managers who have worked together for 10 years, and got a strong record in supply chain and logistics technologies. Our success is rooted in our deep domain expertise and wide industry network.
- Industry Venture Capital and Private Equity Principals
- Website https://lfxvp.com/
- LinkedIn https://www.linkedin.com/company/lfx-venture-partners/about/
IC Realtime | $2,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)